New Hope for Alzheimer’s Patients?
Jul 21 at 6:06pm by Aileen
USPS Alzheimer’s Stamp
Rapid Alzheimer’s Improvement After New Immune-based Treatment
The open access journal BMC Neurology published research this week detailing some amazing results from the use of the anti-tumor necrosis factor-alpha [TNF-alpha] drug to treat symptoms of Alzheimer’s Disease from a novel immune system approach. Researchers documented improvement in language function within minutes of administering the drug, tending to confirm preliminary evidence that disrupted neural communication in Alzheimer’s patients may be reversible.
This is a very hopeful development, as are results from clinical drug trials in recent years slowing the progression of the disease in elderly patients as well as ongoing research into substances that may help clear the beta amyloid placques in the brain tissue, characteristic of the disease. As the Baby Boomer generation ages, it is estimated that up to 10 million of them will get this awful disease.
Some doctors are expressing concern about unduly raising hopes in patients and their families on these very early findings. Dr. Sam Gandy, chairman of the Alzheimer’s Association’s medical and science council, has expressed suspicion due to the private nature of the research because the lead researcher has a financial interest in the drug. It is hoped that other laboratories and scientists will be able to duplicate the results, but that more rigorous clinical work remains to be done.
UCLA associate professor of neurology John Ringman and colleagues have reported in the journal Neurology that there may be a way to detect Alzheimer’s even before symptoms appear by measuring the level of certain proteins in the blood and spinal fluid. These proteins are potentially useful biomarkers to identify and track progression of the disease before the patient shows any signs of deteriorating mental acuity.
The amount of suffering for the families of those 10 million people could be reduced drastically if there were effective treatments, so there is a good deal of public and private research ongoing. Hopefully when the Boomers reach an age where they have ready access to medical care via Medicare, diagnosis and treatment will be available to them.
Big Pharma’s Big Lie Refuted
Jan 8 at 5:05pm by Aileen
Two York University researchers have published a study in the January 3rd issue of PLoS Medicine [Public Library of Science] demonstrating that U.S. pharmaceutical companies spend nearly twice as much money promoting their drugs to doctors and the public than on research and development of new drugs.
Big Pharma Spends More on Advertising than Research and Development puts the lie to the pharmaceutical industry’s self-serving mantra that the cost of drugs in the U.S. has to be higher than anywhere else in the world so that newer, better drugs - and drugs designed to treat relatively rare but deadly diseases - can be developed. High prices for prescription drugs offset this massive expenditure, they tell us, and the U.S. government has tended to accept the lie without challenge.
RECENT COMMENTS